Capricor Therapeutics
CAPR
#7633
Rank
HK$3.45 B
Marketcap
HK$59.49
Share price
0.80%
Change (1 day)
32.96%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): -HK$19.14

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$19.20. In 2025 the company made an earnings per share (EPS) of -HK$17.72 a decrease over its 2024 EPS that were of -HK$9.41.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$19.148.05%
2025-HK$17.7288.33%
2024-HK$9.41
2022-HK$9.2535.63%
2021-HK$6.82-7.45%
2020-HK$7.37-55.45%
2019-HK$16.54-59.81%
2018-HK$41.15-1850%
2017HK$2.35-102.94%
2016-HK$79.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$54.64-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$47.35 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.10 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$59.18 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$229.59 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA